Recombinant human basic fibroblast growth factor (Nanhai Longtime Pharmaceutical/Jinan University)

外用重组人碱性成纤维细胞生长因子（南海朗肽）

Report date: 2024/11/20 09:57:22

Base Information

Drug NameRecombinant human basic fibroblast growth factor (Nanhai Longtime Pharmaceutical/Jinan University)
Drug Alias Namerh-bFGF (Nanhai Longtime Pharmaceutical/Jinan University)Gaifu盖扶
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionFibroblast growth factor receptors agonists
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsSurgical WoundWounds and Injuries
Global Approved IndicationsWounds and Injuries
Approved Indications in ChinaWounds and Injuries
Original Approved Country/TerritoryMainland China
Original Approved Date2004/07/26
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJinan University
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesNanhai Langtai Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSurgical WoundWounds and Injuries
Inactive IndicationsN/A

Other Information

ATC CodeD03
Related LinksN/A